Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by mediascan59on May 10, 2010 3:25pm
345 Views
Post# 17081821

RE: RE: Nice to see the gap filled

RE: RE: Nice to see the gap filledRe: midas4
No, what I am saying is that we gapped at .445 and I didn't want the gap to haunt us going forward. The gap was filled when it traded at .44, which takes that out of the equation.
We now will test that .46 we hit a couple times earlier today.
What I see is that we will either close at the day high or make a new high before the end of the trading day today.
If so, we will most likely gap tomorrow morning and go through the same pattern once again until some news presents itself.

Mediascan
Bullboard Posts